MEDITECH(SH:603990)2017-10-26 16:00Financial Performance - Operating revenue increased by 14.44% to CNY 166,600,031.89 for the first nine months of the year[6] - Net profit attributable to shareholders increased by 35.26% to CNY 29,259,530.39 for the first nine months of the year[6] - Total operating revenue for Q3 2017 was CNY 61,781,770.47, an increase of 14.8% compared to CNY 54,188,986.45 in Q3 2016[29] - Net profit for Q3 2017 reached CNY 15,579,365.46, representing a 38.8% increase from CNY 11,277,413.33 in Q3 2016[30] - Net profit for the first nine months of 2017 reached CNY 28,429,207.93, up 45.3% from CNY 19,575,084.65 in the same period last year[32] - The company reported a total profit of CNY 14,987,971.03 for Q3 2017, an increase of 12.9% from CNY 13,267,673.77 in Q3 2016[32] Cash Flow - Cash flow from operating activities showed a negative net amount of CNY -51,170,428.66, compared to CNY -25,842,352.75 in the same period last year[6] - The net cash flow from operating activities for the first nine months of 2017 was negative CNY 51,170,428.66, worsening from negative CNY 25,842,352.75 in the same period last year[35] - Net cash flow from operating activities for Q3 2017 was -CNY 51,192,672.85, compared to -CNY 20,100,793.97 in Q3 2016, indicating a decline[38] - Cash received from sales of goods and services for the first nine months of 2017 was CNY 144,105,287.49, compared to CNY 132,383,252.54 in the same period last year[37] - Cash inflow from investment activities in Q3 2017 totaled CNY 131,179,907.24, a significant increase from CNY 298,023.10 in Q3 2016[38] Assets and Liabilities - Total assets decreased by 15.26% to CNY 585,004,085.06 compared to the end of the previous year[6] - The total assets as of September 30, 2017, were RMB 585 million, down from RMB 690 million at the beginning of the year[21] - The total liabilities decreased from RMB 295 million to RMB 174.77 million during the same period[22] - Current liabilities totaled CNY 204,413,801.51, down from CNY 244,831,746.66 in the previous year, indicating a reduction of 16.5%[26] - The total liabilities decreased to CNY 208,417,756.31 from CNY 324,881,539.26, showing a significant reduction of 35.9%[26] Equity and Shareholder Information - The number of shareholders reached 7,738 at the end of the reporting period[9] - The company's total equity increased from RMB 394.97 million to RMB 410.23 million, reflecting a positive growth in retained earnings[22] - The company's total equity increased to CNY 387,929,897.19 from CNY 373,500,689.24, marking a growth of 3.9%[26] Expenses - Management expenses rose by RMB 19.97 million, a 46.29% increase, mainly attributed to higher R&D costs, employee salaries, and depreciation[13] - Financial expenses increased by RMB 1.20 million, a significant growth of 190.81%, mainly due to interest from long-term loans after the headquarters building became operational[13] - Sales expenses for the first nine months of 2017 were CNY 50,356,959.68, up 7.1% from CNY 46,692,856.73 in the same period last year[31] - The company’s financial expenses for the first nine months of 2017 were CNY 1,831,363.99, significantly higher than CNY 636,662.52 in the same period last year[31] Inventory and Prepaid Accounts - Inventory increased by 41.94% to CNY 610,250.00, primarily due to project stocking and costs of unfinished projects[11] - Prepaid accounts increased by 196.71% to CNY 998,200.00, mainly for advancing procurement payments[11] Other Financial Metrics - The weighted average return on equity decreased by 3.71 percentage points to 7.25%[7] - The company reported a basic and diluted earnings per share of CNY 0.36, unchanged from the previous year[7] - The gross profit margin for Q3 2017 was approximately 11.8%, compared to 10.4% in Q3 2016, indicating improved profitability[29] - Research and development expenses were CNY 24,418,330.98 for Q3 2017, up from CNY 17,773,471.32 in the same quarter last year, reflecting a 37.2% increase[29]